This Day On The Street
Continue to site right-arrow
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Cramer's Action Alerts PLUS - See his portfolio and get alerts BEFORE every trade. Learn more NOW!

How we keep our portfolio free of exuberance

By Barrack Yard Advisors

An old adage in the financial markets for seekers of value is 'follow the misery.' The concept of misery is subjective and means different things to different people but the basic idea is that disappointed investors bid down prices to eventual bargain levels.

Times of great misery for investors such as March 2009 coincide with terrific buying opportunities for patient, long-term owners of good businesses.

The opposite of misery is exuberance. This is when risk-taking is well-rewarded and the financial markets appear benevolent. Many participants attribute investment success in such an environment to their own special insight. A bubble is when exuberance becomes so pronounced that the seeds of capital destruction are sown due to extreme overvaluation.

In a bubble prices rise to levels that imply perpetually low or negative returns because investors pay too much for future cash flows. High-quality businesses like Microsoft (MSFT), Oracle (ORCL) and Cisco (CSCO) famously reached this level of overvaluation during the dot.com bubble of the late 1990s.

In the first quarter of 2014, valuations for many American stocks reached late 1990s' bubble levels. Internet names like Twitter (TWTR), Yelp (YELP), LinkedIn (LNKD) and Facebook (FB), and 3D printers like Stratasys (SSYS) and 3D Systems (DDD) represented overvaluation risk in the extreme.

History suggests two things about owning extremely overvalued stocks. First, they can remain expensive for years and warnings against owning them can look foolish. Second, owning them will eventually end in losses as it is impossible to make a timely exit: how does one know if a drop in the share price is simply a "healthy" correction or the beginning of a long misery cycle?

We use numerous metrics to guide us in our search for great businesses selling at good prices. We begin with the overall level of the stock market and with some exception we believe the US market is currently exuberant. How exuberant? Were the US market to rise another 30% without an equal or greater rise in corporate earnings, we believe American stocks would then be classified as being in a bubble.

During the first quarter we made several changes to the Covestor Core International Portfolio. In the US we believe there remain pockets of attractive valuation and therefore added to our position in IBM. We continue to be pleased with our ownership of Cisco (CSCO) and DuPont (DD), the global agriculture and other services giant.

We initiated a new position in Aqua America (WTR), a quality US water firm that we characterize as a predictable growth utility. We also added Baxter International (BAX), the diversified healthcare company with an long term track record of increasing shareholder value through dividend increases and share buybacks.

Most of our activity has been in markets outside the US that are not exuberant by any measure. As a group emerging markets fit into this category given that EM stock prices are lower now than they were 3-years ago.

This misery has created an opportunity in our opinion and we believe a "conservative" way of participating in the emerging markets is through ownership of Chile-based Andina, a Coca-Cola bottler since 1946 with businesses in Chile, Brazil, Paraguay and Argentina. As well, we own Coca-Cola Amatil, an Australian bottler with extensive interests in Indonesia. The Coca-Cola Company has a major ownership stake in both firms.

In the fourth quarter of 2013, we added Singapore-based conglomerate Jardine Matheson (JARD) whose major businesses are focused principally on Asia. They are involved in engineering and construction, transportation services, property investment and development, retailing, restaurants, and agriculture. Their luxury hotel group, Mandarin Oriental, is well-known to most business travelers. The shares are selling at roughly its book value.

In Hong Kong we added Hutchison Whampoa, the ports-to-property conglomerate that is entering a divestiture cycle to enhance shareholder value. Most of Hutchison's holdings are in Asia, including significant infrastructure assets, but they own Husky Oil in Canada and telecom firms in Europe. The shares trade at a discount to net asset value.

We implemented a new position in growth stock SGS, a Swiss-based global leader in the testing & inspection industry. SGS is profitable and may continue to benefit from globalization and increased outsourcing of testing and inspection services. Finally, we maintain a 15% cash position awaiting good entry points for companies on our shopping list.

In summary, we believe none of the companies in the Core Portfolio is at an exuberant level of valuation and some are even priced for misery.

DISCLAIMER: The investments discussed are held in client accounts as of March 31, 2013. These investments may or may not be currently held in client accounts. The reader should not assume that any investments identified were or will be profitable or that any investment recommendations or investment decisions we make in the future will be profitable. Past performance is no guarantee of future results.

Barrack Yard Advisors

Barrack Yard Advisors

Portfolio Manager Martin Leclerc is a 30-year veteran of the investment management business. He began his career at Dean Witter

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Try it NOW
Only $9.95
Try it NOW
14-Days Free
Try it NOW

Check Out Our Best Services for Investors

Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
Try it NOW
Try it NOW
Try it NOW
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
SYM TRADE IT LAST %CHG

Markets

DOW 18,288.63 +155.93 0.86%
S&P 500 2,116.91 +12.41 0.59%
NASDAQ 5,007.17 +43.6430 0.88%

Partners Compare Online Brokers

Free Reports

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs